Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Lanning Mark R, Director. Director active across 1 company, notably AtriCure, Inc.. Cumulatively, 3 filings have been logged. History available since 5 May 2021. The latest transaction was filed on 5 May 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Mark R. Lanning is a Director at AtriCure, Inc. In this role, he participates in the strategic direction of the company and important decision-making. His expertise in the medical sector is valuable to the board.